Clusterin siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemClusterin siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-43688
Gene Nameclusterin
Quantity10 µM
Specieshuman
NCBI Full Gene Nameclusterin
NCBI Gene AliasesAAG4, APO-J, APOJ, CLI, CLU1, CLU2, KUB1, NA1/NA2, SGP-2, SGP2, SP-40, TRPM-2, TRPM2
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Clusterin can mediate apoptosis-induced molecular mechanisms in immune thrombocytopeniaBlood Vessels, Thrombosis & HemostasisSeptember 1, 2024Tea Stein, Christina Bitsina, Michelle Seiler, Markus Schmugge, Francesca D. Franzosoper well were plated in a 24-well plate. MEG-01 cells were incubated with siRNAs gene against CLU (sc-43688) and GRP78 (sc-29338), or negative control siRNA (sc-44230, using siRNA transfection reagent [sc-29528],

(2) Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathwayLife sciencesJanuary 1, 2021Naik PP, Mukhopadhyay S, Praharaj PP, Bhol CS, Panigrahi DP, Mahapatra KK, Patra S, Saha S, Panda AK, Panda K, et al.

(3) sCLU as prognostic biomarker and therapeutic target in osteosarcomaBioengineeredDecember 1, 2019Ma J, Gao W, Gao J.transfection sCLU and control siRNA were purchased from Santa Cruz Biotechnology (Shanghai, China; sc-43688). KHOS cells were transfected with the siRNAs at a final concentration of 100 nM using Lipofectamine

(4) Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cellsWorld journal of surgical oncologyAugust 9, 2014Huang H, Wang L, Li M, Wang X, Zhang L.

(5) Clusterin confers resistance to TNF-alpha-induced apoptosis in breast cancer cells through NF-kappaB activation and Bcl-2 overexpressionJournal of chemotherapy (Florence, Italy)December 1, 2012Wang Y, Wang X, Zhao H, Liang B, Du Q.

Be the First to Write a Review!